Activation of CAMK2 by pseudokinase PEAK1 represents a targetable pathway in triple negative breast cancer. - Yang X; Ma X; Zhao T; Croucher DR; Nguyen EV; Clark KC; Hu C; Latham SL; Bayly-Jones C; Nguyen BV; Budnar S; Shin SY; et al. (Nature communications, 2025)